Stock comparison
IDEXX Laboratories
Tenet Healthcare
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
THC
Tenet Healthcare
Market cap
$14.97B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | THC | Winner |
|---|---|---|---|
| Warren Buffett | 75B | 55C | IDXX |
| Benjamin Graham | 80A | 73B | IDXX |
| Philip Fisher | 75B | 47D | IDXX |
| Peter Lynch | 71B | 41D | IDXX |
| Joel Greenblatt | 83C | 32F | IDXX |
| Charlie Munger | 87A | 50D | IDXX |
| Terry Smith | 84A | 52D | IDXX |
Side-by-side metrics
| Metric | IDXX | THC |
|---|---|---|
| Market cap | $44.12B | $14.97B |
| P/E (TTM) | 39.0x | 9.8x |
| EV/EBIT | 31.6x | 7.8x |
| ROIC (TTM) | 40.66% | 11.53% |
| Gross margin | 62.05% | 42.76% |
| Net margin | 24.63% | 7.94% |
| Revenue CAGR 5y | 7.56% | 2.26% |
| EPS CAGR 5y | 10.79% | 16.24% |
| Debt / Equity | 0.7x | 2.7x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- Debt / Equity0.7xvs 2.7x+75%
- ROIC (TTM)40.66%vs 11.53%+72%
- Revenue CAGR 5y7.56%vs 2.26%+70%
- Net margin24.63%vs 7.94%+68%
THC leads on
- EV/EBIT7.8xvs 31.6x+75%
- P/E (TTM)9.8xvs 39.0x+75%
- EPS CAGR 5y16.24%vs 10.79%+34%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.